Trial Profile
Clinical Trials Insight: 700041892
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Sep 2022
Price :
$35
*
At a glance
- Drugs HMPL 002 (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- Sponsors Hutchison MediPharma; HUTCHMED
- 23 Feb 2009 New trial record.